肺栓塞致院外心脏骤停复苏中溶栓可提高30天生存率:法国国家心脏骤停登记研究
本研究基于法国国家心脏骤停登记数据,回顾性纳入2011年7月至2018年3月因肺栓塞导致院外心脏骤停且入院确诊的成人患者246例,比较复苏中溶栓组与对照组预后。
要点
- 肺栓塞所致院外心脏骤停患者复苏中溶栓与30天生存率提高相关(16% vs 6%)。
- 溶栓组与对照组良好神经功能预后无显著差异(10% vs 5%)。
- 研究为回顾性观察性多中心设计,需前瞻性研究进一步验证。
核心结论
- 在因肺栓塞导致院外心脏骤停且入院时恢复自主循环的患者中,复苏中接受溶栓治疗者30天生存率显著高于未溶栓者。
研究设计与样本
- 回顾性、观察性、多中心研究,纳入2011年7月至2018年3月法国国家心脏骤停登记中因肺栓塞导致院外心脏骤停的成人患者,最终分析246例。
主要发现
- 良好神经功能预后溶栓组为10%,对照组为5%,调整相对风险1.97(95%CI 0.70-5.56),无显著差异。
- 溶栓药物使用情况:阿替普酶14例(24%)、替奈普酶43例(74%)、链激酶1例(2%)。
临床怎么用
- 对于确诊肺栓塞所致院外心脏骤停且入院恢复自主循环的患者,复苏中溶栓可能改善30天生存,但需权衡神经功能预后不确定性。
局限性
- 回顾性观察性设计可能存在选择偏倚和混杂因素。
- 样本量较小(246例),溶栓组仅58例,统计效能有限。
- 良好神经功能预后无显著差异,需进一步研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary embolism (PE) represents 2% to 5% of all causes of out-of-hospital cardiac arrest (OHCA) and is associated with extremely unfavorable prognosis. In PE-related OHCA, inconsistent data showed that thrombolysis during cardiopulmonary resuscitation may favor survival. METHODS: This was a retrospective, observational, multicenter study from July 2011 to March 2018. All adults with OHCA, treated by a mobile ICU and with a diagnosis of PE confirmed on hospital admission, were included. The primary end point was 30-day survival in a weighted population. RESULTS: Of the 14,253 patients admitted to hospitals, 328 had a final diagnosis of PE and 246 were included in the analysis. In the group that received thrombolysis during resuscitation (n = 58), 14 (24%) received alteplase, 43 (74%) received tenecteplase, and one (2%) received streptokinase. Thirty-day survival was higher in the thrombolysis group than in the control group (16% vs 6%; P = .005; adjusted log-rank test) but the good neurologic outcome was not significantly different (10% vs 5%; adjusted relative risk, 1.97; 95% CI, 0.70-5.56). Median duration of stay in the ICU was 1 (0-5) day for the thrombolysis group and 1 (0-3) day for the control group (P = .23). CONCLUSIONS: In patients with OHCA with confirmed PE and admitted with recuperation of spontaneous circulation in the hospital, there was significantly higher 30-day survival in those who received thrombolysis during cardiopulmonary resuscitation compared with patients who did not receive thrombolysis.
引用
- Javaudin F, Lascarrou JB, Le Bastard Q, et al. Thrombolysis During Resuscitation for Out-of-Hospital Cardiac Arrest Caused by Pulmonary Embolism Increases 30-Day Survival: Findings From the French National Cardiac Arrest Registry. Chest. 2019. PMID: 31381884. doi:10.1016/j.chest.2019.07.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。